Adamis pharmaceuticals reports second quarter 2023 financial results and provides corporate update

San diego, aug. 21, 2023 (globe newswire) -- adamis pharmaceuticals corporation (nasdaq: admp), a commercial-stage biopharmaceutical company, today announced financial results for the second quarter ended june 30, 2023, and provided an update on recent corporate developments.

ADMP Ratings Summary

ADMP Quant Ranking